We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

China Pharma Holdings Inc (CPHI) USD0.001

Sell:$0.16 Buy:$0.16 Change: $0.0146 (9.16%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$0.16
Buy:$0.16
Change: $0.0146 (9.16%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$0.16
Buy:$0.16
Change: $0.0146 (9.16%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

Contact details

Address:
2nd Floor, No. 17, Jinpan Road, Haikou
HAIKOU
570216
China
Telephone:
+86 (898) 66811730
Website:
www.chinapharmaholdings.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CPHI
ISIN:
US16941T3023
Market cap:
$3.34 million
Shares in issue:
19.25 million
Sector:
Pharmaceuticals
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Zhilin Li
    Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.